Recursion to Participate in Upcoming Investor Conferences
- Tuesday, February 8, 2022, 8:02
- Finance
- Add a comment
SALT LAKE CITY, Feb. 8, 2022 /PRNewswire/ — Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following upcoming investor conferences: SVB Leerink 11th Annual Global Healthcare…
About the Author
adminasapcorp has written 41558 stories on this site.